Plitidepsin
- Generic Name
- Plitidepsin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C57H87N7O15
- CAS Number
- 137219-37-5
- Unique Ingredient Identifier
- Y76ID234HW
- Background
Aplidine is a peptide found in tunicates which shows promise in shrinking tumors in pancreatic, stomach, bladder, and prostate cancers. The specific marine organism is Aplidium albicans. Aplidine is also of interest as a potential treatment for some leukemias.
- Indication
Intended for the treatment of various forms of cancer.
- Associated Conditions
- -
- Associated Therapies
- -
Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post-COVID-19 Condition (PCC)
Phase 2
Not yet recruiting
- Conditions
- Post COVID-19 ConditionLong COVID SyndromePersistent COVID-19Persistent COVID ConditionLong COVID
- Interventions
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
- Target Recruit Count
- 90
- Registration Number
- NCT06766825
- Locations
- 🇪🇸
Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath